120 related articles for article (PubMed ID: 38484492)
21. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
22. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
Akbayir O; Corbacioglu A; Goksedef BP; Numanoglu C; Akca A; Guraslan H; Bakir LV; Cetin A
Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
[TBL] [Abstract][Full Text] [Related]
23. Nodal infiltration in endometrial cancer: a prediction model using best subset regression.
Matsumoto YK; Himoto Y; Nishio M; Kikkawa N; Otani S; Ito K; Yamanoi K; Kato T; Fujimoto K; Kurata Y; Moribata Y; Yoshida H; Minamiguchi S; Mandai M; Kido A; Nakamoto Y
Eur Radiol; 2024 May; 34(5):3375-3384. PubMed ID: 37882835
[TBL] [Abstract][Full Text] [Related]
24. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
[TBL] [Abstract][Full Text] [Related]
25. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.
Dogan Altunpulluk M; Kir G; Topal CS; Cetiner H; Gocmen A
J Obstet Gynaecol; 2015 May; 35(4):397-402. PubMed ID: 25279582
[TBL] [Abstract][Full Text] [Related]
26. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
27. Predicting Factors for Pelvic Lymph Node Metastasis in Patients with Apparently Early-Stage Endometrial Cancer.
Gumtorntip P; Poomtavorn Y; Tanprasertkul C
Asian Pac J Cancer Prev; 2022 Feb; 23(2):617-622. PubMed ID: 35225474
[TBL] [Abstract][Full Text] [Related]
28. Is it possible to predict para-aortic lymph node metastasis in endometrial cancer?
Turan T; Hizli D; Sarici S; Boran N; Gundogdu B; Karadag B; Tulunay G; Kose MF
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):274-9. PubMed ID: 21664758
[TBL] [Abstract][Full Text] [Related]
29. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
30. The prediction of para-aortic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
Numanoglu C; Corbacioglu Esmer A; Ulker V; Goksedef BP; Han A; Akbayir O; Guraslan B
J Obstet Gynaecol; 2014 Feb; 34(2):177-81. PubMed ID: 24456443
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
Larson DM; Johnson KK; Reyes CN; Broste SK
Obstet Gynecol; 1994 Sep; 84(3):399-403. PubMed ID: 8058238
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus.
Sarı ME; Meydanlı MM; Yalçın I; Şahin H; Çoban G; Çelik H; Kuşçu E; Gungor T; Ayhan A
Oncol Res Treat; 2018; 41(12):750-754. PubMed ID: 30419557
[TBL] [Abstract][Full Text] [Related]
33. Patterns of lymph node metastases and their implications in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with endometrial cancer.
Teng F; Yu H; Wang B; Yan Y; Gao C; Guo F; Gao J; Tian W; Wang Y; Xue F
J Cancer; 2022; 13(14):3575-3583. PubMed ID: 36484012
[No Abstract] [Full Text] [Related]
34. Does para-aortic lymphadenectomy improve survival in pathologically diagnosed early-stage grade 3 endometrioid and non-endometrioid endometrial cancers? A retrospective cohort study in Korea and Taiwan.
Lai YL; Chang CS; Chang K; Kim HS; Chen J; Cheng WF; Chen YL; Lee YY
Gynecol Oncol; 2022 Oct; 167(1):65-72. PubMed ID: 35995599
[TBL] [Abstract][Full Text] [Related]
35. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
[TBL] [Abstract][Full Text] [Related]
36. Lower uterine segment involvement in lymphovascular space invasion and lymph node metastasis in endometrioid endometrial cancer.
Cokmez H; Yilmaz A
Ginekol Pol; 2019; 90(6):314-319. PubMed ID: 31276182
[TBL] [Abstract][Full Text] [Related]
37. Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer.
Zanfagnin V; Huang Y; Mc Gree ME; Weaver AL; Casarin J; Multinu F; Cappuccio S; Ferrero A; Mariani A; Glaser GE
Gynecol Oncol; 2019 Sep; 154(3):480-486. PubMed ID: 31324453
[TBL] [Abstract][Full Text] [Related]
38. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
Mariani A; Dowdy SC; Cliby WA; Gostout BS; Jones MB; Wilson TO; Podratz KC
Gynecol Oncol; 2008 Apr; 109(1):11-8. PubMed ID: 18304622
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
[TBL] [Abstract][Full Text] [Related]
40. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
